Denosumab vs Placebo in Patients With Thalassemia Major and Osteoporosis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
This is a single-site, randomized, placebo-controlled, double blind phase 2b clinical trial. Patients with Thalassemia will participate in this study and will be treated with Denosumab or placebo. The effect of Denosumab on lumbar spine BMD in patients with Thalassemia Major and Osteoporosis will be evaluated as compared with control (placebo) at 12 months.
Epistemonikos ID: 6aa926f84e394aa2e12121780354ef4b14ef1a80
First added on: May 12, 2024